HNRG vs. RYTM
HNRG (Hallador Energy Company) and RYTM (Rhythm Pharmaceuticals, Inc.) are both stocks. HNRG operates in Thermal Coal (Energy), while RYTM operates in Biotechnology (Healthcare). Over the past 5 years, HNRG returned 41.97%/yr vs 35.88%/yr for RYTM. At a 0.12 correlation, their price movements are largely independent.
Performance
HNRG vs. RYTM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HNRG achieves a -13.66% return, which is significantly higher than RYTM's -17.43% return.
HNRG
- 1D
- 1.92%
- 1M
- -15.35%
- YTD
- -13.66%
- 6M
- -26.28%
- 1Y
- 1.73%
- 3Y*
- 27.40%
- 5Y*
- 41.97%
- 10Y*
- 15.56%
RYTM
- 1D
- 0.82%
- 1M
- -5.70%
- YTD
- -17.43%
- 6M
- -22.17%
- 1Y
- 40.24%
- 3Y*
- 70.57%
- 5Y*
- 35.88%
- 10Y*
- —
HNRG vs. RYTM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
HNRG Hallador Energy Company | -13.66% | 66.29% | 29.52% | -11.51% | 306.10% | 67.35% | -49.34% | -39.39% | -14.71% | 6.70% |
RYTM Rhythm Pharmaceuticals, Inc. | -17.43% | 91.21% | 21.78% | 57.86% | 191.78% | -66.43% | 29.49% | -14.58% | -7.50% | 25.20% |
Correlation
The correlation between HNRG and RYTM is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.13 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.15 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.14 |
Correlation (All Time) Calculated using the full available price history since Oct 5, 2017 | 0.12 |
Fundamentals
HNRG:
$764.77M
RYTM:
$6.01B
HNRG:
$0.51
RYTM:
-$3.10
HNRG:
1.60
RYTM:
26.75
HNRG:
3.72
RYTM:
732.99
HNRG:
$453.49M
RYTM:
$217.17M
HNRG:
$79.39M
RYTM:
$194.16M
HNRG:
$71.97M
RYTM:
-$182.86M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HNRG vs. RYTM — Risk / Return Rank
HNRG
RYTM
HNRG vs. RYTM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Hallador Energy Company (HNRG) and Rhythm Pharmaceuticals, Inc. (RYTM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| HNRG | RYTM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.68 | ||
| Sortino ratioReturn per unit of downside risk | -1.17 | ||
| Omega ratioGain probability vs. loss probability | 1.06 | 1.19 | -0.13 |
| Calmar ratioReturn relative to maximum drawdown | 0.05 | 1.14 | -1.09 |
| Martin ratioReturn relative to average drawdown | 0.09 | 2.64 | -2.55 |
Loading charts...
Drawdowns
HNRG vs. RYTM - Drawdown Comparison
The maximum HNRG drawdown since its inception was -94.89%, roughly equal to the maximum RYTM drawdown of -92.10%. Use the drawdown chart below to compare losses from any high point for HNRG and RYTM.
Loading charts...
Drawdown Indicators
| HNRG | RYTM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.89% | -92.10% | -2.79% |
Max Drawdown (1Y)Largest decline over 1 year | -36.62% | -35.54% | -1.08% |
Max Drawdown (3Y)Largest decline over 3 years | -71.13% | -35.54% | -35.59% |
Max Drawdown (5Y)Largest decline over 5 years | -71.13% | -85.49% | +14.36% |
Max Drawdown (10Y)Largest decline over 10 years | -93.19% | — | — |
Current DrawdownCurrent decline from peak | -30.95% | -24.86% | -6.09% |
Average DrawdownAverage peak-to-trough decline | -45.06% | -32.15% | -12.91% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 19.59% | 15.31% | +4.28% |
Volatility
HNRG vs. RYTM - Volatility Comparison
Hallador Energy Company (HNRG) has a higher volatility of 18.60% compared to Rhythm Pharmaceuticals, Inc. (RYTM) at 11.87%. This indicates that HNRG's price experiences larger fluctuations and is considered to be riskier than RYTM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HNRG | RYTM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.60% | 11.87% | +6.73% |
Volatility (6M)Calculated over the trailing 6-month period | 45.72% | 36.41% | +9.31% |
Volatility (1Y)Calculated over the trailing 1-year period | 60.67% | 57.20% | +3.47% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 71.73% | 76.39% | -4.66% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 69.69% | 71.57% | -1.88% |
Dividends
HNRG vs. RYTM - Dividend Comparison
Neither HNRG nor RYTM has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
HNRG Hallador Energy Company | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.72% | 5.39% | 3.16% | 2.63% | 1.76% | 3.51% |
RYTM Rhythm Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
HNRG vs. RYTM - Financials Comparison
This section allows you to compare key financial metrics between Hallador Energy Company and Rhythm Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
HNRG vs. RYTM - Profitability Comparison
HNRG - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Hallador Energy Company reported a gross profit of 59.46M and revenue of 101.81M. Therefore, the gross margin over that period was 58.4%.
RYTM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Rhythm Pharmaceuticals, Inc. reported a gross profit of 52.96M and revenue of 60.11M. Therefore, the gross margin over that period was 88.1%.
HNRG - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Hallador Energy Company reported an operating income of -5.65M and revenue of 101.81M, resulting in an operating margin of -5.6%.
RYTM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Rhythm Pharmaceuticals, Inc. reported an operating income of -52.36M and revenue of 60.11M, resulting in an operating margin of -87.1%.
HNRG - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Hallador Energy Company reported a net income of -9.32M and revenue of 101.81M, resulting in a net margin of -9.2%.
RYTM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Rhythm Pharmaceuticals, Inc. reported a net income of -56.74M and revenue of 60.11M, resulting in a net margin of -94.4%.
Frequently Asked Questions
HNRG and RYTM have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HNRG has higher volatility (18.60%) compared to RYTM (11.87%). In terms of maximum drawdown, HNRG dropped -94.89% vs RYTM's -92.10%.
RYTM currently has the higher Sharpe Ratio (0.71 vs 0.03), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HNRG and RYTM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer